Thrombotic Stroke occurs when a blood clot formed in an artery supplying blood to the brain, blocking the flow of oxygen and other vital nutrients. This type of stroke is very serious and can lead to death or permanent disability if not treated quickly. The most common cause of a thrombotic stroke is atherosclerosis, a type of artery disease. Atherosclerosis occurs when fatty deposits, or plaque, accumulate on the walls of arteries, narrowing them and eventually blocking the artery completely. This blockage is called a thrombus. If this thrombus restricts or completely cuts off the flow of blood, a thrombotic stroke can occur. Other risk factors for thrombotic stroke include high cholesterol, high blood pressure, diabetes, smoking, and abnormal heart rhythms. Too little physical activity and unhealthy eating habits are also thought to increase the risk of a thrombotic stroke. The symptoms of a thrombotic stroke may include sudden numbness or weakness in the face, arms, or legs; confusion; difficulty understanding or speaking; loss of balance or coordination; trouble walking; sudden trouble seeing; or a severe headache. Treatment of a thrombotic stroke should be done as quickly as possible and includes medications to help dissolve the blood clot, such as tissue plasminogen activator (tPA). Additional medications may also be prescribed to lower the risk of future strokes. Surgery can also be performed to remove the clot if medications are not effective. Preventing a thrombotic stroke means managing lifestyle and health risks. Eating a heart-healthy diet, exercising regularly, quitting smoking, and having regular check-ups can all help reduce the risk of thrombotic stroke. Additionally, medications such as blood thinners may be prescribed to prevent blood clots from forming.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom